Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.69
-0.04-2.31%
At close: Sep 18, 5:00 PM EST
$1.70
0.00950.56%
After Hours: Sep 18, 5:13 PM EST
Allogene Therapeutics Inc (ALLO) Stock Price, Quote, News & History
ALLONASDAQ
Allogene Therapeutics (ALLO) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Allogene Therapeutics (ALLO) stock?
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Who are Allogene Therapeutics (ALLO) competitors?
Other companies in Allogene Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?
Allogene Therapeutics has a consensus price target of $7.68.
What is the current price for Allogene Therapeutics (ALLO)?
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $1.6995 last updated September 18, 2026 at 5:13 PM EDT.
Does Allogene Therapeutics (ALLO) pay a dividend?
There are no upcoming dividends for Allogene Therapeutics.
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics does not have any upcoming earnings scheduled.
Is Allogene Therapeutics (ALLO) going to split?
There is no upcoming split for Allogene Therapeutics.
What sector and industry does Allogene Therapeutics (ALLO) operate in?
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
